PHILADELPHIA, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Scout Bio today announced that Mark Heffernan, Chief Executive Officer, will present at the upcoming Wells Fargo Virtual Healthcare Conference on Thursday, September 9, 2021 at 4:00 p.m. ET.
About Scout Bio
Scout Bio is a biotechnology company revolutionizing pet medicine by delivering a pipeline of one-time gene therapies for major chronic pet health conditions. Scout Bio’s therapeutics are designed to induce long-term expression of therapeutic proteins in pet patients using AAV vector technology. Scout Bio has a research and development collaboration with the University of Pennsylvania’s Gene Therapy Program, a leader in the field of genetic medicine research. Scout Bio is a private company headquartered in Philadelphia, Pennsylvania. For more information, see www.scoutbio.co
For further information, please contact:
Investors:
Sarah McCabe
Stern Investor Relations, Inc.
212.362.1200
sarah.mccabe@sternir.com
Media:
Fran Gaconnier
Scout Bio
212.417.4142
fran.gaconnier@scoutbio.co
